Related Experiment Video
Updated: Jul 10, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Antiphospholipid antibodies and thrombosis
1Department of Medicine and Therapeutics, Foresterhill, Aberdeen, UK. m.greaves@abdn.ac.uk
Lancet (London, England)
|April 28, 1999
Summary
Antiphospholipid antibodies indicate a risk for blood clots and pregnancy loss. Identifying antiphospholipid syndrome is crucial for managing recurrent thrombosis and guiding antithrombotic therapy.
Area of Science:
- Immunology
- Hematology
- Obstetrics
Background:
- Antiphospholipid antibodies are linked to thrombosis, recurrent pregnancy loss, and thrombocytopenia.
- These antibodies serve as key laboratory markers for antiphospholipid syndrome (APS).
Purpose of the Study:
- To highlight the clinical importance of identifying APS due to risks of recurrent thrombosis.
- To underscore the need for antithrombotic therapy in many APS cases.
Main Methods:
- Review of clinical associations and laboratory markers for APS.
- Analysis of diagnostic challenges and treatment limitations.
Main Results:
- APS identification is critical for managing recurrent thrombotic events.
- Effective antithrombotic therapy is often required for APS patients.
Conclusions:
- Diagnosis and management of APS are complicated by diverse clinical features.
- Limitations in current antibody testing and lack of evidence-based guidelines hinder optimal patient care.
More Related Videos
Related Concept Videos
01:38Inflammation
Overview
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...